BankPlus Trust Department Lowers Holdings in UnitedHealth Group Incorporated $UNH

BankPlus Trust Department trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 2,693 shares of the healthcare conglomerate’s stock after selling 287 shares during the period. BankPlus Trust Department’s holdings in UnitedHealth Group were worth $840,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the company. Focused Investors LLC lifted its stake in UnitedHealth Group by 21.8% during the second quarter. Focused Investors LLC now owns 504,000 shares of the healthcare conglomerate’s stock worth $157,233,000 after purchasing an additional 90,100 shares in the last quarter. Shell Asset Management Co. lifted its stake in UnitedHealth Group by 19.8% during the second quarter. Shell Asset Management Co. now owns 66,912 shares of the healthcare conglomerate’s stock worth $20,875,000 after purchasing an additional 11,036 shares in the last quarter. Tyche Wealth Partners LLC lifted its stake in UnitedHealth Group by 8.3% during the second quarter. Tyche Wealth Partners LLC now owns 5,127 shares of the healthcare conglomerate’s stock worth $1,599,000 after purchasing an additional 394 shares in the last quarter. KLP Kapitalforvaltning AS raised its stake in shares of UnitedHealth Group by 3.2% in the second quarter. KLP Kapitalforvaltning AS now owns 326,335 shares of the healthcare conglomerate’s stock valued at $101,807,000 after acquiring an additional 10,100 shares in the last quarter. Finally, Hardy Reed LLC raised its stake in shares of UnitedHealth Group by 41.7% in the second quarter. Hardy Reed LLC now owns 5,933 shares of the healthcare conglomerate’s stock valued at $1,851,000 after acquiring an additional 1,745 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH opened at $363.95 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The business’s 50-day moving average price is $311.44 and its 200 day moving average price is $352.42. The firm has a market cap of $329.62 billion, a P/E ratio of 15.77, a P/E/G ratio of 2.33 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the prior year, the business earned $6.80 EPS. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on UNH shares. Bank of America increased their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research note on Monday, August 18th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Barclays raised their price target on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. KeyCorp cut their price target on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Finally, Wells Fargo & Company raised their price target on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Hold” and a consensus target price of $365.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.